Michael Herman

1.2k total citations
22 papers, 959 citations indexed

About

Michael Herman is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Michael Herman has authored 22 papers receiving a total of 959 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 8 papers in Surgery and 8 papers in Oncology. Recurrent topics in Michael Herman's work include Bladder and Urothelial Cancer Treatments (5 papers), Prostate Cancer Diagnosis and Treatment (4 papers) and Urinary and Genital Oncology Studies (4 papers). Michael Herman is often cited by papers focused on Bladder and Urothelial Cancer Treatments (5 papers), Prostate Cancer Diagnosis and Treatment (4 papers) and Urinary and Genital Oncology Studies (4 papers). Michael Herman collaborates with scholars based in United States, Canada and Switzerland. Michael Herman's co-authors include Uwe Schönbeck, Galina K. Sukhova, Peter Libby, Norbert Gerdes, Daniel B. Horton, Roger E. Breitbart, Shahrokh F. Shariat, Peter Libby, Walter Kisiel and Marilyn R. Kehry and has published in prestigious journals such as Circulation, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

Michael Herman

20 papers receiving 937 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Herman United States 11 387 355 239 228 184 22 959
Michele De Nictolis Italy 19 219 0.6× 264 0.7× 326 1.4× 333 1.5× 269 1.5× 52 1.3k
Konrad Ptaszyński Poland 16 130 0.3× 170 0.5× 249 1.0× 184 0.8× 369 2.0× 47 846
Ji Eun Kwon South Korea 17 221 0.6× 85 0.2× 198 0.8× 188 0.8× 172 0.9× 61 786
Yoshiharu Maeda Japan 20 225 0.6× 293 0.8× 613 2.6× 327 1.4× 215 1.2× 60 1.3k
Hiroyuki Takamura Japan 13 162 0.4× 98 0.3× 222 0.9× 213 0.9× 350 1.9× 56 875
Nadia M. Bambace Canada 9 110 0.3× 306 0.9× 505 2.1× 308 1.4× 118 0.6× 40 987
Valeria Zuccalà Italy 20 122 0.3× 257 0.7× 210 0.9× 548 2.4× 128 0.7× 55 1.1k
Francisco J. Martínez‐Tello Spain 21 279 0.7× 201 0.6× 485 2.0× 538 2.4× 361 2.0× 42 1.6k
Zahid Kaleem United States 21 270 0.7× 117 0.3× 352 1.5× 329 1.4× 316 1.7× 49 1.3k
Agnès Basire France 14 98 0.3× 126 0.4× 107 0.4× 334 1.5× 60 0.3× 30 737

Countries citing papers authored by Michael Herman

Since Specialization
Citations

This map shows the geographic impact of Michael Herman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Herman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Herman more than expected).

Fields of papers citing papers by Michael Herman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Herman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Herman. The network helps show where Michael Herman may publish in the future.

Co-authorship network of co-authors of Michael Herman

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Herman. A scholar is included among the top collaborators of Michael Herman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Herman. Michael Herman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schmid, Sabine, Miguel García-Pardo, Kristen Dietrich, et al.. (2024). Immediate Versus Deferred Systemic Therapy in Patients With Mesothelioma. Clinical Lung Cancer. 25(7). e277–e285.e3.
2.
Azhie, Amirhossein, Robert C. Grant, Michael Herman, et al.. (2022). Phase II clinical trial of cabozantinib for the treatment of recurrent hepatocellular carcinoma after liver transplantation. Future Oncology. 18(18). 2173–2191. 2 indexed citations
3.
Schmid, Sabine, Kristen Dietrich, Michael Herman, et al.. (2021). Treatment Patterns and Outcomes of Patients With Advanced Pleural Mesothelioma at an Academic Referral Centre. Clinical Lung Cancer. 23(1). e43–e53. 3 indexed citations
4.
Halpern, Joshua A., Khushabu Kasabwala, Michael Herman, et al.. (2018). Multiple Regions of Interest on Multiparametric Magnetic Resonance Imaging are Not Associated with Increased Detection of Clinically Significant Prostate Cancer on Fusion Biopsy. The Journal of Urology. 200(3). 559–563. 9 indexed citations
5.
Kennedy, William R., Michael Herman, Rohan Deraniyagala, et al.. (2016). Radiotherapy alone or combined with chemotherapy as definitive treatment for squamous cell carcinoma of the tonsil. European Archives of Oto-Rhino-Laryngology. 273(8). 2117–2125. 7 indexed citations
6.
Herman, Michael, Runjan Chetty, Brendan C. Dickson, et al.. (2015). Desmoplastic Small Round Cell Tumor Presenting as an Isolated Testicular Mass in an Adult With Multiple Previous Malignancies. Clinical Genitourinary Cancer. 14(2). e221–e223. 1 indexed citations
7.
Herman, Michael, Roi Dagan, Robert J. Amdur, et al.. (2014). Postoperative radiotherapy for patients at high risk of recurrence of oral cavity squamous cell carcinoma. The Laryngoscope. 125(3). 630–635. 16 indexed citations
8.
Rieken, Malte, Luis Kluth, Évanguelos Xylinas, et al.. (2013). Association of diabetes mellitus and metformin use with biochemical recurrence in patients treated with radical prostatectomy for prostate cancer. World Journal of Urology. 32(4). 999–1005. 34 indexed citations
9.
Raman, Jay D., Matthew Kaag, Paul L. Crispen, et al.. (2013). High rates of advanced disease, complications, and decline of renal function after radical nephroureterectomy. Urologic Oncology Seminars and Original Investigations. 32(1). 47.e9–47.e14. 58 indexed citations
10.
11.
Scherr, Douglas S., et al.. (2012). A 38-Year-old Woman With Multiple Renal Masses and a History of Ovarian Cancer. Urology. 79(6). 1210–1213. 1 indexed citations
12.
Sooriakumaran, Prasanna, Majnu John, Paul J. Christos, et al.. (2011). Models to Predict Positive Prostate Biopsies Using the Tyrol Screening Study. Urology. 78(4). 924–929. 4 indexed citations
13.
Messer, Jamie, John D. Terrell, Michael Herman, et al.. (2011). Multi-institutional validation of the ability of preoperative hydronephrosis to predict advanced pathologic tumor stage in upper-tract urothelial carcinoma. Urologic Oncology Seminars and Original Investigations. 31(6). 904–908. 65 indexed citations
14.
Herman, Michael, Philip Dorsey, Majnu John, et al.. (2009). Techniques and predictive models to improve prostate cancer detection. Cancer. 115(S13). 3085–3099. 9 indexed citations
15.
Herman, Michael, Robert S. Svatek, Yair Lotan, Pierre Karakiewizc, & Shahrokh F. Shariat. (2008). Urine-based biomarkers for the early detection and surveillance of non-muscle invasive bladder cancer.. PubMed. 60(4). 217–35. 37 indexed citations
16.
Svatek, Robert S., Michael Herman, Yair Lotan, et al.. (2006). Soluble Fas—A promising novel urinary marker for the detection of recurrent superficial bladder cancer. Cancer. 106(8). 1701–1707. 49 indexed citations
17.
Shariat, Shahrokh F., Michael Herman, Roberto Casella, et al.. (2005). Urinary Levels of Tumor-Associated Trypsin Inhibitor (TATI) in the Detection of Transitional Cell Carcinoma of the Urinary Bladder. European Urology. 48(3). 424–431. 18 indexed citations
18.
Herman, Michael, Galina K. Sukhova, Walter Kisiel, et al.. (2001). Tissue factor pathway inhibitor-2 is a novel inhibitor of matrix metalloproteinases with implications for atherosclerosis. Journal of Clinical Investigation. 107(9). 1117–1126. 185 indexed citations
19.
Herman, Michael, Galina K. Sukhova, Peter Libby, et al.. (2001). Expression of Neutrophil Collagenase (Matrix Metalloproteinase-8) in Human Atheroma. Circulation. 104(16). 1899–1904. 276 indexed citations
20.
Schönbeck, Uwe, François Mach, Galina K. Sukhova, et al.. (1999). Expression of Stromelysin-3 in Atherosclerotic Lesions: Regulation via CD40–CD40 Ligand Signaling In Vitro and In Vivo. The Journal of Experimental Medicine. 189(5). 843–853. 128 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michele De Nictolis Breakdown of academic impact, for papers by Konrad Ptaszyński Breakdown of academic impact, for papers by Ji Eun Kwon Breakdown of academic impact, for papers by Yoshiharu Maeda Breakdown of academic impact, for papers by Hiroyuki Takamura Breakdown of academic impact, for papers by Nadia M. Bambace Breakdown of academic impact, for papers by Valeria Zuccalà Breakdown of academic impact, for papers by Francisco J. Martínez‐Tello Breakdown of academic impact, for papers by Zahid Kaleem Breakdown of academic impact, for papers by Agnès Basire
Rankless by CCL
2026